<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39375504</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1530-0447</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>07</Day></PubDate></JournalIssue><Title>Pediatric research</Title><ISOAbbreviation>Pediatr Res</ISOAbbreviation></Journal><ArticleTitle>Clinical characteristics and outcomes of COVID-19 in pediatric patients with rheumatic diseases.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41390-024-03561-1</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">This study investigates the clinical characteristics and outcomes of pediatric patients with rheumatic diseases infected with COVID-19 in China.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a retrospective analysis of pediatric patients with rheumatic diseases who contracted COVID-19. Data were collected via a comprehensive questionnaire with a 14-day follow-up. Multivariable logistic regression was used to assess severe outcomes, and network analyses evaluated symptom correlations.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 1070 cases were collected. Fever (88.05%) and cough (62.75%) were the most common symptoms. Cough, nasal congestion, and runny nose exhibited a stronger correlation with each other. A higher incidence of fever reduced the incidence of two single symptoms (nasal congestion [r = -0.833], runny nose [r = -0.762]). Vaccinated children showed a shorter time to negative COVID-19 conversion (7.21 days vs. 7.63 days, p &lt; 0.05) and lower hospitalization rates (p = 0.025). Prolonged symptom duration was associated with older age (OR: 1.07 [1.04-1.11]; p &lt; 0.001) and systemic lupus erythematosus (OR: 1.47 [1.01-2.12]; p = 0.046).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Pediatric patients with rheumatic diseases exhibited a wide range of clinical symptoms after COVID-19 infection. The infection generally did not lead to severe outcomes in this study. COVID-19 vaccination was associated with reduced hospitalization risk and expediting the time to negativity for virus.</AbstractText><AbstractText Label="IMPACTS" NlmCategory="CONCLUSIONS">This manuscript demonstrates a comprehensive analysis of the clinical characteristics and outcomes of COVID-19 infection in pediatric patients with rheumatic diseases in China. It provides critical insights into the specific challenges faced by this vulnerable population and offers practical recommendations for improving patient management during periods of increased infectious risk.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Wang</LastName><ForeName>Yating</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders. Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Su</LastName><ForeName>Shu</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Ma</LastName><ForeName>Mingsheng</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Weng</LastName><ForeName>Ruohang</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Rheumatology &amp; Immunology Department of Shenzhen Children's Hospital, Shenzhen, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Zhiyong</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders. Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Dawei</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders. Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Xin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders. Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Junjun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders. Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, Chongqing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yajun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, The First People's Hospital of Yunnan Province, Kunming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Pediatric Immunology and Rheumatology Department, Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, 611731, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Sirui</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of pediatric rheumatology, immunology, and allergy, The First Hospital of Jilin University, Changchun, Jilin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Hongxia</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Pediatric Nephrology, Rheumatology and Immunology, Children's Hospital Affiliated to Shandong University, Jinan Children's Hospital, Jinan, Shandong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Dongmei</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, Children's Hospital of Urumqi, No.1 Jiankang Rd., TianShan Distinct, Urumqi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Meiping</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Rheumatology Immunology and Allergy, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xiaoqing</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, Xi'an Children's Hospital, Xi'an, 710068, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Jia</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, The Affiliated Children's Hospital, Capital Institute of Pediatrics, 2 Yabao Road, Chaoyang District, 100020, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Weixi</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Pediatric Allergy and Immunology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, 325027, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Haiguo</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, Children's Hospital of Nanjing Medical University No. 72 Guangzhou Road, Nanjing, 210008, Jiangsu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Dongfeng</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Pediatric Nephrology, Children's Hospital of Hebei Province affiliated to Hebei Medical University, Shijiazhuang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Yanjie</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, 450046, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nong</LastName><ForeName>Guangmin</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, The First Affiliated Hospital of Guangxi Medical University, Nanning, 530021, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cai</LastName><ForeName>Xuxu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Shengjing Hospital of China Medical University, Shenyang, 110004, Liaoning, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mao</LastName><ForeName>Huawei</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Immunology, Ministry of Education Key Laboratory of Major Diseases in Children, Beijing Children's Hospital, National Center for Children's Health, Capital Medical University, No. 56 Nanlishi Road, 100045, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Fei</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Immunology, Ministry of Education Key Laboratory of Major Diseases in Children, Beijing Children's Hospital, National Center for Children's Health, Capital Medical University, No. 56 Nanlishi Road, 100045, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Xiaochuan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, The Second Xiangya Hospital, Central South University, Changsha, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rong</LastName><ForeName>Zanhua</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of paediatrics, The Second Hospital of Hebei Medical University, Shijiazhuang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Jianjiang</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of paediatrics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Zhixiang</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Inner Mongolia Autonomous Region People's Hospital, Hohhot, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Xinhui</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Guiyang Maternal and Child Health Care Hospital (Guiyang Children's Hospital), Guiyang, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xiaozhong</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Nephrology and Immunology, Children's Hospital of Soochow University, Suzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xuemei</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Qilu Children's Hospital of Shandong University, Jinan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Chongwei</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Rheumatology &amp; Immunology, Tianjin Children's Hospital, No. 238 Longyan Road, Beichen District, Tianjin, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Lifeng</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Provincial Hospital Affiliated to Shandong University, Jinan, 250021, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Sihao</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Jun</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Rheumatology &amp; Immunology Department of Shenzhen Children's Hospital, Shenzhen, China. rogasansz@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Hongmei</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China. songhm1021@126.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tang</LastName><ForeName>Xuemei</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders. Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, Chongqing, China. tangxuemei2008@163.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Chinese Alliance of Pediatric Rheumatic and Immunologic Diseases</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>07</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Pediatr Res</MedlineTA><NlmUniqueID>0100714</NlmUniqueID><ISSNLinking>0031-3998</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>7</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>0</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>8</Day><Hour>0</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>7</Day><Hour>23</Hour><Minute>36</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39375504</ArticleId><ArticleId IdType="doi">10.1038/s41390-024-03561-1</ArticleId><ArticleId IdType="pii">10.1038/s41390-024-03561-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>The Lancet editorial. Emerging understandings of 2019-nCoV. Lancet 395, 311 (2020).</Citation></Reference><Reference><Citation>Epidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Zhonghua Liu Xing Bing Xue Za Zhi 41, 145–151 (2020).</Citation></Reference><Reference><Citation>Setiabudi, D., Sribudiani, Y., Hermawan, K., Andriyoko, B. &amp; Nataprawira, H. M. The Omicron variant of concern: The genomics, diagnostics, and clinical characteristics in children. Front. Pediatrics 10, 898463 (2022).</Citation></Reference><Reference><Citation>Tian, D., Sun, Y., Xu, H. &amp; Ye, Q. The emergence and epidemic characteristics of the highly mutated SARS-CoV-2 Omicron variant. J. Med. Virol. 94, 2376–2383 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27643</ArticleId><ArticleId IdType="pubmed">35118687</ArticleId><ArticleId IdType="pmc">9015498</ArticleId></ArticleIdList></Reference><Reference><Citation>Tariq, S., Van Eeden, C., Tervaert, J. W. C. &amp; Osman, M. S. COVID-19, rheumatic diseases and immune dysregulation-a perspective. Clin. Rheumatol. 40, 433–442 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-020-05529-y</ArticleId><ArticleId IdType="pubmed">33411143</ArticleId><ArticleId IdType="pmc">7788381</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong, J. et al. COVID-19 in patients with rheumatic disease in Hubei province, China: a multicentre retrospective observational study. Lancet Rheumatol. 2, e557–e564 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2665-9913(20)30227-7</ArticleId><ArticleId IdType="pubmed">32838309</ArticleId><ArticleId IdType="pmc">7333992</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelena, X. et al. Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs. Semin. Arthritis Rheumatism 50, 564–570 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semarthrit.2020.05.001</ArticleId><ArticleId IdType="pubmed">32425260</ArticleId></ArticleIdList></Reference><Reference><Citation>Haslak, F. et al. Comparisons of Clinical Features and Outcomes of COVID-19 between Patients with Pediatric Onset Inflammatory Rheumatic Diseases and Healthy Children. J. Clin. Med. 11, 2102 (2022).</Citation></Reference><Reference><Citation>Sze, S. et al. Ethnicity and clinical outcomes in COVID-19: A systematic review and meta-analysis. EClinicalMedicine 29, 100630 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100630</ArticleId><ArticleId IdType="pubmed">33200120</ArticleId></ArticleIdList></Reference><Reference><Citation>Walters, H. M. et al. Seroprevalence and clinical outcomes of SARS-CoV-2 in paediatric patients with rheumatic disease. Rheumatology 61, SI112–SI119 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keab730</ArticleId><ArticleId IdType="pubmed">34599820</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikolopoulou, G. B. &amp; Maltezou, H. C. COVID-19 in Children: Where do we Stand? Arch. Med. Res. 53, 1–8 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arcmed.2021.07.002</ArticleId><ArticleId IdType="pubmed">34311990</ArticleId></ArticleIdList></Reference><Reference><Citation>Cloete, J. et al. Paediatric hospitalisations due to COVID-19 during the first SARS-CoV-2 omicron (B.1.1.529) variant wave in South Africa: a multicentre observational study. Lancet Child Adolesc. Health 6, 294–302 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(22)00027-X</ArticleId><ArticleId IdType="pubmed">35189083</ArticleId><ArticleId IdType="pmc">8856663</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu, X. et al. SARS-CoV-2 Infection in Children. N. Engl. J. Med. 382, 1663–1665 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2005073</ArticleId><ArticleId IdType="pubmed">32187458</ArticleId></ArticleIdList></Reference><Reference><Citation>Coronavirus Disease 2019 in Children - United States, February 12-April 2, 2020. MMWR Morb. Mortal Wkly Rep. 69, 422–426 (2020).</Citation></Reference><Reference><Citation>Clemente, D. et al. Clinical characteristics and COVID-19 outcomes in a regional cohort of pediatric patients with rheumatic diseases. Pediatr. Rheumatol. 19, 162 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12969-021-00648-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Monti, S. et al. Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies. Ann. Rheum. Dis. 79, 667–668 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-217424</ArticleId><ArticleId IdType="pubmed">32241793</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson, M. C., Manos, C. K., Flanagan, E. &amp; Prahalad, S. COVID-19 after rituximab therapy in cSLE patients. Ther. Adv. Vaccines Immunother. 11, 25151355231181242 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/25151355231181242</ArticleId><ArticleId IdType="pubmed">37362155</ArticleId><ArticleId IdType="pmc">10285438</ArticleId></ArticleIdList></Reference><Reference><Citation>Sozeri, B. et al. The clinical course of SARS-CoV-2 infection among children with rheumatic disease under biologic therapy: a retrospective and multicenter study. Rheumatol. Int. 42, 469–475 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-021-05008-w</ArticleId><ArticleId IdType="pubmed">34570263</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson, P. C. &amp; Morand, E. Divergent effects of acute versus chronic glucocorticoids in COVID-19. Lancet Rheumatol. 3, e168–e170 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2665-9913(21)00005-9</ArticleId><ArticleId IdType="pubmed">33521656</ArticleId><ArticleId IdType="pmc">7833899</ArticleId></ArticleIdList></Reference><Reference><Citation>Wakiguchi, H. et al. Clinical Features of COVID-19 in Pediatric Rheumatic Diseases: 2020-2022 Survey of the Pediatric Rheumatology Association of Japan. Viruses 15, 1205 (2023).</Citation></Reference><Reference><Citation>Lu, C. F. et al. Clinical presentation and risk factors of SARS-Cov-2 infections in chinese patients with rheumatic disease. Chin. J. Allergy Immunol. 17, 423–429 (2023).</Citation></Reference><Reference><Citation>Zhang, N. et al. Immunophenotype of lymphocytes and real-world outcome of COVID-19 infection in children with hematology and oncology. BMC Cancer 24, 538 (2024).</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12885-024-12262-1</ArticleId><ArticleId IdType="pubmed">38678181</ArticleId><ArticleId IdType="pmc">11056048</ArticleId></ArticleIdList></Reference><Reference><Citation>Frenkel, L. D., Gomez, F. &amp; Bellanti, J. A. COVID-19 in children: Pathogenesis and current status. Allergy Asthma Proc. 42, 8–15 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.2500/aap.2021.42.200104</ArticleId><ArticleId IdType="pubmed">33404385</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin, W. et al. Structures of the Omicron spike trimer with ACE2 and an anti-Omicron antibody. Science 375, 1048–1053 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abn8863</ArticleId><ArticleId IdType="pubmed">35133176</ArticleId></ArticleIdList></Reference><Reference><Citation>Cameroni, E. et al. Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift. Nature 602, 664–670 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-04386-2</ArticleId><ArticleId IdType="pubmed">35016195</ArticleId></ArticleIdList></Reference><Reference><Citation>Weisberg, S. P. et al. Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum. Nat. Immunol. 22, 25–31 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-020-00826-9</ArticleId><ArticleId IdType="pubmed">33154590</ArticleId></ArticleIdList></Reference><Reference><Citation>Götzinger, F. et al. COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study. Lancet Child Adolesc. Health 4, 653–661 (2020).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(20)30177-2</ArticleId><ArticleId IdType="pubmed">32593339</ArticleId><ArticleId IdType="pmc">7316447</ArticleId></ArticleIdList></Reference><Reference><Citation>Payne, A. B. et al. Incidence of Multisystem Inflammatory Syndrome in Children Among US Persons Infected With SARS-CoV-2. JAMA Netw. Open 4, e2116420 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.16420</ArticleId><ArticleId IdType="pubmed">34110391</ArticleId><ArticleId IdType="pmc">8193431</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandes, Q. et al. Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines. Ann. Med 54, 524–540 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2022.2031274</ArticleId><ArticleId IdType="pubmed">35132910</ArticleId><ArticleId IdType="pmc">8843115</ArticleId></ArticleIdList></Reference><Reference><Citation>Alqanatish, J. et al. COVID-19 and Pediatric Rheumatology: A Comprehensive Study from a Leading Tertiary Center in Saudi Arabia. J. Epidemiol. Glob. Health 13, 676–684 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s44197-023-00142-z</ArticleId><ArticleId IdType="pubmed">37594620</ArticleId><ArticleId IdType="pmc">10686932</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu, C. C. et al. Short-term persistent symptoms in preschool children with mild/common coronavirus disease 2019 caused by Omicron variant infection after discharge: a follow-up study. Zhongguo Dang Dai Er Ke Za Zhi 24, 1289–1294 (2022).</Citation></Reference><Reference><Citation>Grainger, R., Kim, A. H. J., Conway, R., Yazdany, J. &amp; Robinson, P. C. COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations. Nat. Rev. Rheumatol. 18, 191–204 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-022-00755-x</ArticleId><ArticleId IdType="pubmed">35217850</ArticleId><ArticleId IdType="pmc">8874732</ArticleId></ArticleIdList></Reference><Reference><Citation>Bijlsma, J. W. J. EULAR December 2020 viewpoints on SARS-CoV-2 vaccination in patients with RMDs. Ann. Rheum. Dis. 80, 411 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-219773</ArticleId><ArticleId IdType="pubmed">33563595</ArticleId></ArticleIdList></Reference><Reference><Citation>Landewé, R. B. M. et al. EULAR recommendations for the management and vaccination of people with rheumatic and musculoskeletal diseases in the context of SARS-CoV-2: the November 2021 update. Ann. Rheum. Dis. 81, 1628–1639 (2022).</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2021-222006</ArticleId><ArticleId IdType="pubmed">35197264</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>